Christodoulakis A, Bouloukaki I, Aravantinou-Karlatou A, Zografakis-Sfakianakis M, Tsiligianni I
Vaccines (Basel). 2025; 12(12).
PMID: 39772072
PMC: 11680286.
DOI: 10.3390/vaccines12121411.
Rurik I, Torzsa P
Healthcare (Basel). 2024; 12(17).
PMID: 39273808
PMC: 11395073.
DOI: 10.3390/healthcare12171785.
Pagano L, Glenn N, Hutchinson K, Long J, Braithwaite J, Sarkies M
Int J Equity Health. 2024; 23(1):167.
PMID: 39169362
PMC: 11337736.
DOI: 10.1186/s12939-024-02249-6.
Abu El Kheir-Mataria W, Khadr Z, El Fawal H, Chun S
Front Public Health. 2024; 12:1348088.
PMID: 38577285
PMC: 10993910.
DOI: 10.3389/fpubh.2024.1348088.
Kulchar R, Singh R, Ding S, Alexander E, Leong K, Daniell H
Biomaterials. 2023; 302:122312.
PMID: 37690380
PMC: 10840840.
DOI: 10.1016/j.biomaterials.2023.122312.
Attitude and Acceptance towards COVID-19 Booster Doses among Literacy Advantaged Population in Pakistan: A Cross-Sectional Study.
Ahmad M, Sattar A, Aroosa S, Majeed A, Rasheed M, Ahmad W
Vaccines (Basel). 2023; 11(7).
PMID: 37515053
PMC: 10383426.
DOI: 10.3390/vaccines11071238.
Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake.
De Domenico M
PLOS Glob Public Health. 2023; 3(6):e0001917.
PMID: 37342998
PMC: 10284420.
DOI: 10.1371/journal.pgph.0001917.
Innovative, rapid, high-throughput method for drug repurposing in a pandemic-A case study of SARS-CoV-2 and COVID-19.
Bello S, Yunusa A, Adamu A, Imam M, Bello M, Shuaibu A
Front Pharmacol. 2023; 14:1130828.
PMID: 36937851
PMC: 10014809.
DOI: 10.3389/fphar.2023.1130828.
Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
Haldane V, Ariyarajah A, Berry I, Loutet M, Salamanca-Buentello F, Upshur R
PLoS One. 2023; 18(2):e0281358.
PMID: 36780502
PMC: 9925066.
DOI: 10.1371/journal.pone.0281358.
COVID-19 vaccine and booster hesitation around the world: A literature review.
Shah A, C Coiado O
Front Med (Lausanne). 2023; 9:1054557.
PMID: 36714110
PMC: 9878297.
DOI: 10.3389/fmed.2022.1054557.
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
Bedston S, Lowthian E, Jarvis C, Akbari A, Beggs J, Bradley D
Vaccine. 2023; 41(7):1378-1389.
PMID: 36669966
PMC: 9837216.
DOI: 10.1016/j.vaccine.2023.01.023.
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants.
Rodriguez-Aponte S, Dalvie N, Wong T, Johnston R, Naranjo C, Bajoria S
Vaccine. 2023; 41(5):1108-1118.
PMID: 36610932
PMC: 9797419.
DOI: 10.1016/j.vaccine.2022.12.062.
Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) serology in the vaccination era and post booster vaccination.
Dulipsingh L, Lang M, Diffenderfer M, Cook L, Puff J, Diaz L
J Clin Virol Plus. 2022; 3(1):100130.
PMID: 36568023
PMC: 9759815.
DOI: 10.1016/j.jcvp.2022.100130.
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Omma A, Batirel A, Aydin M, Karadag F, Erden A, Kucuksahin O
Hum Vaccin Immunother. 2022; 18(6):2122503.
PMID: 36315843
PMC: 9746394.
DOI: 10.1080/21645515.2022.2122503.
Evolving trend change during the COVID-19 pandemic.
Gao L, Zheng C, Shi Q, Xiao K, Wang L, Liu Z
Front Public Health. 2022; 10:957265.
PMID: 36203708
PMC: 9531778.
DOI: 10.3389/fpubh.2022.957265.
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study....
Silva-Valencia J, Soto-Becerra P, Escobar-Agreda S, Fernandez-Navarro M, Elorreaga O, Mayta-Tristan P
Vaccine. 2022; 40(45):6512-6519.
PMID: 36202642
PMC: 9515342.
DOI: 10.1016/j.vaccine.2022.09.066.
Non-pharmacological interventions of travel restrictions and cancelation of public events had a major reductive mortality affect during pre-vaccination coronavirus disease 2019 period.
Wen H, Shi F, Liu Y, Xie C, Qin G, Wang F
Front Med (Lausanne). 2022; 9:914732.
PMID: 36072943
PMC: 9441752.
DOI: 10.3389/fmed.2022.914732.
The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
Qin W, Zhang X, Wang Y, Pan F, Cheng K, Huang F
Front Public Health. 2022; 10:943876.
PMID: 35979461
PMC: 9376472.
DOI: 10.3389/fpubh.2022.943876.
Modeling a sustainable vaccine supply chain for a healthcare system.
Chowdhury N, Ahmed M, Mahmud P, Paul S, Liza S
J Clean Prod. 2022; 370:133423.
PMID: 35975192
PMC: 9372915.
DOI: 10.1016/j.jclepro.2022.133423.
Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean.
Urrunaga-Pastor D, Fernandez-Guzman D, Caira-Chuquineyra B, Herrera-Anazco P, Benites-Zapata V, Bendezu-Quispe G
Travel Med Infect Dis. 2022; 50:102409.
PMID: 35961489
PMC: 9361628.
DOI: 10.1016/j.tmaid.2022.102409.
